Reviva Pharmaceuticals Holdings, Inc. Stock
Equities
RVPH
US76152G1004
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -2.86% | -0.74% | -74.17% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 41.74M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.8M | Net cash position 2025 * | 1.2M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-1.58
x | Employees | 15 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.42% |
1 day | -2.86% | ||
1 week | -0.74% | ||
Current month | -2.91% | ||
1 month | -54.76% | ||
3 months | -64.91% | ||
6 months | -65.27% | ||
Current year | -74.17% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 20-12-10 | |
Narayan Prabhu
DFI | Director of Finance/CFO | 53 | 20-12-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 69 | 20-12-13 | |
Les Funtleyder
BRD | Director/Board Member | 54 | 20-12-13 |
Founder | 59 | 20-12-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 1.367 | -2.33% | 14 293 |
24-06-04 | 1.4 | -6.67% | 127,083 |
24-06-03 | 1.5 | +9.49% | 267,844 |
24-05-31 | 1.37 | 0.00% | 91,689 |
24-05-30 | 1.37 | +2.24% | 171,084 |
Delayed Quote Nasdaq, June 05, 2024 at 09:43 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.17% | 41.74M | |
+49.60% | 55.7B | |
+38.76% | 39.91B | |
-6.47% | 39.57B | |
-6.65% | 28.16B | |
+12.99% | 26.3B | |
-21.50% | 18.94B | |
+29.67% | 12.17B | |
+26.02% | 12.12B | |
-0.15% | 12.12B |
- Stock Market
- Equities
- RVPH Stock